Designing New Antimicrobials Based on Known Valuable Heterocycles as Building Blocks

Abstract submission deadline

31 January 2025

Manuscript submission deadline

31 March 2025

Viewed by

287

Topic Information

Dear Colleagues,

Heterocycles are essential structural components in various antimicrobial drugs. The significance of heterocycles in drug design resides in their ability to modify the drug candidate’s physicochemical characteristics, biological impact, and pharmacokinetic and toxicological profile. Numerous recent studies have targeted therapeutic agents with heterocycle-based structures. In the last decade, diverse heterocyclic compounds have been synthesized to develop new antimicrobials capable of treating bacterial, viral, fungal, or parasitic infections. The physicochemical properties imparted by a heterocycle are associated with the biological activity of the drug (the spectrum of activity and potency) and its pharmacokinetic, pharmacologic, and toxicological profiles. Highlighting the relationships between heterocycles in the molecular structure of antimicrobial drugs and their biological properties can serve as the basis for many other rational design studies for discovering new antimicrobials (antibiotics, antivirals, antifungals, and antiparasitics). Incorporating valuable heterocycles into the molecular structure of antimicrobials represents a promising avenue for advancing drug development. It offers opportunities to enhance drug efficacy, safety, and diversity, which is crucial in the ongoing battle with infections, parasitosis, and resistance to antimicrobials. As a result of drug resistance in bacteria, fungi, HIV, tuberculosis, malaria, and tropical diseases, antibiotics and other antimicrobial drugs become ineffective, and infections become difficult or impossible to treat, increasing the risk of disease, severe illness, disability, and death.

This Topic focuses on the rational design of novel antimicrobials by leveraging the structural diversity and pharmacological potential of known valuable heterocycles as fundamental building blocks. Continued research is essential to translate all promising findings into effective treatments that benefit global public health. The proposed Topic aims to identify the latest trends in discovering new antimicrobials based on valuable heterocycles as building blocks and will welcome both research papers and reviews.

Prof. Dr. Aura Rusu
Prof. Dr. Gabriel Hancu
Dr. Vladimír Garaj
Topic Editors

Keywords

Participating Journals

Journal Name	Impact Factor	CiteScore	Launched Year	First Decision (median)	APC
Antibiotics antibiotics	4.8	5.5	2012	13.7 Days	CHF 2900	Submit
International Journal of Molecular Sciences ijms	5.6	7.8	2000	16.3 Days	CHF 2900	Submit
Molecules molecules	4.6	6.7	1996	14.6 Days	CHF 2700	Submit
Pharmaceutics pharmaceutics	5.4	6.9	2009	14.2 Days	CHF 2900	Submit
Scientia Pharmaceutica scipharm	2.5	6.4	1930	22.7 Days	CHF 1000	Submit

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

1. Immediately share your ideas ahead of publication and establish your research priority;
2. Protect your idea from being stolen with this time-stamped preprint article;
3. Enhance the exposure and impact of your research;
4. Receive feedback from your peers in advance;
5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers